|
| 1 |
Treatment-free remission after discontinuation of imatinib, dasatinib, and nilotinib in patients with chronic myeloid leukemia
Jae Joon Han
Blood Res.2023;58(S1):S58-S65. Published online 2023 April 7
DOI: http://dx.doi.org/10.5045/br.2023.2023035
|
|
| 2 |
Whole-Genome and Transcriptome Sequencing Identified NOTCH2 and HES1 as Potential Markers of Response to Imatinib in Desmoid Tumor (Aggressive Fibromatosis): A Phase II Trial Study
Joonha Kwon, Jun Hyeong Lee, Young Han Lee, Jeeyun Lee, Jin-Hee Ahn, Se Hyun Kim, Seung Hyun Kim, Tae Il Kim, Kum-Hee Yun, Young Suk Park, Jeong Eun Kim, Kyu Sang Lee, Jung Kyoon Choi, Hyo Song Kim
Cancer Res Treat.2022;54(4):1240-1255. Published online 2022 January 17
DOI: http://dx.doi.org/10.4143/crt.2021.1194
|
|
| 3 |
직장에 발생한 거대한 위장관 기질종양의 성공적인 내시경 절제
Seong Jung Kim, Yun Jung, Ran Hong, Jun Lee
|
|
| 4 |
Identification of a Novel CSNK2A1-PDGFRB Fusion Gene in a Patient with Myeloid Neoplasm with Eosinophilia
Xiaoyu Xu, Qiongyu Lu, Zheng Wang, Ping Cai, Zhao Zeng, Ling Zhang, Man Wang, Liang Ma, Changgeng Ruan, Suning Chen
Cancer Res Treat.2021;53(3):889-892. Published online 2020 December 24
DOI: http://dx.doi.org/10.4143/crt.2020.1272
|
|
| 5 |
초고령 환자에서 위의 위장관 기질 종양 수술 후 나타난 반복적인 문합부 재발
Hye-Jin Kim, Jae Yong Park, Beom Jin Kim, Jae Gyu Kim, Hee Sung Kim and Joong-Min Park
|
|
| 6 |
Use of generic imatinib as first-line treatment in patients with chronic myeloid leukemia (CML): the GIMS (Glivec to Imatinib Switch) study
Maria Gemelli, Elena Maria Elli, Chiara Elena, Alessandra Iurlo, Tamara Intermesoli, Margherita Maffioli, Ester Pungolino, Maria Cristina Carraro, Mariella D’Adda, Francesca Lunghi, Michela Anghileri, Nicola Polverelli, Marianna Rossi, Mattia Bacciocchi, Elisa Bono, Cristina Bucelli, Francesco Passamonti, Laura Antolini, Carlo Gambacorti-Passerini
Blood Res.2020;55(3):139-145. Published online 2020 September 30
DOI: http://dx.doi.org/10.5045/br.2020.2020130
|
|
| 7 |
Neuroprotective potential of imatinib in global ischemia-reperfusion-induced cerebral injury: possible role of Janus-activated kinase 2/signal transducer and activator of transcription 3 and connexin 43
Jieying Wang, Taomin Bai, Nana Wang, Hongyan Li, Xiangyang Guo
|
|
| 8 |
Factors Influencing Imatinib-Induced Hepatotoxicity
Ji Min Han, Jeong Yee, Yoon Sook Cho, Hye Sun Gwak
Cancer Res Treat.2020;52(1):181-188. Published online 2019 June 26
DOI: http://dx.doi.org/10.4143/crt.2019.131
|
|
| 9 |
ABCB1 and BMI1 mRNA expression in patients with chronic myeloid leukemia: impact on imatinib efficacy
Ahmed M. L. Bedewy, Shereen M. Elmaghraby, Noha S. Kandil
Blood Res.2019;54(1):57-62. Published online 2019 March 21
DOI: http://dx.doi.org/10.5045/br.2019.54.1.57
|
|
| 10 |
Imatinib-induced hepatitis treated by corticosteroids in a patient with metastatic gastrointestinal stromal tumor
Min Kyu Kang, Heon Ju Lee, Joon Hyuk Choi
|
|
| 11 |
Myeloid and lymphoid neoplasm with eosinophilia and abnormalities of PDGFRB presenting as congestive heart failure and hypereosinophilia
Jae-Woo Kwon, Ji-Hyun Kwon, Ae-Young Her
|
|
| 12 |
A rare case of osteonecrosis of the jaw related to imatinib
Massimo Viviano, Marco Rossi, Serena Cocca
|
|
| 13 |
Update on Gastrointestinal Stromal Tumors for Radiologists
Sree Harsha Tirumani, Akshay D. Baheti, Harika Tirumani, Ailbhe O'Neill, Jyothi P. Jagannathan
|
|
| 14 |
Efficacy and Safety of Regorafenib in Korean Patients with Advanced Gastrointestinal Stromal Tumor after Failure of Imatinib and Sunitinib: A Multicenter Study Based on the Management Access Program
Myoung Kyun Son, Min-Hee Ryu, Joon Oh Park, Seock-Ah Im, Tae-Yong Kim, Su Jin Lee, Baek-Yeol Ryoo, Sook Ryun Park, Yoon-Koo Kang
Cancer Res Treat.2017;49(2):350-357. Published online 2016 July 19
DOI: http://dx.doi.org/10.4143/crt.2016.067
|
|
| 15 |
Asian Consensus Guidelines for the Diagnosis and Management of Gastrointestinal Stromal Tumor
Dong-Hoe Koo, Min-Hee Ryu, Kyoung-Mee Kim, Han-Kwang Yang, Akira Sawaki, Seiichi Hirota, Jie Zheng, Bo Zhang, Chin-Yuan Tzen, Chun-Nan Yeh, Toshirou Nishida, Lin Shen, Li-Tzong Chen, Yoon-Koo Kang
Cancer Res Treat.2016;48(4):1155-1166. Published online 2016 June 24
DOI: http://dx.doi.org/10.4143/crt.2016.187
|
|
| 16 |
Population pharmacokinetics of imatinib mesylate in healthy Korean subjects
Gab-jin Park, Wan-Su Park, Soohyun Bae, Sung-min Park, Seunghoon Han, Dong-Seok Yim
|
|
| 17 |
A Multi-centric Bioequivalence Trial in Ph+ Chronic Myeloid Leukemia Patients to Assess Bioequivalence and Safety Evaluation of Generic Imatinib Mesylate 400 mg Tablets
Rachna Arora, Manju Sharma, Tausif Monif, Sunil Iyer
Cancer Res Treat.2016;48(3):1120-1129. Published online 2016 February 12
DOI: http://dx.doi.org/10.4143/crt.2015.436
|
|
| 18 |
Favorable outcome of allogeneic hematopoietic stem cell transplantation followed by post-transplant treatment with imatinib in children with Philadelphia chromosome-positive acute lymphoblastic leukemia
Ye Jee Byun, Jin Kyung Suh, Seong Wook Lee, Darae Lee, Hyunjin Kim, Eun Seok Choi, Kyung-Nam Koh, Ho Joon Im, Jong Jin Seo
Blood Res.2015;50(3):147-153. Published online 2015 September 22
DOI: http://dx.doi.org/10.5045/br.2015.50.3.147
|
|
| 19 |
Severe Imatinib-Associated Skin Rash in Gastrointestinal Stromal Tumor Patients: Management and Clinical Implications
Sook Ryun Park, Min-Hee Ryu, Baek-Yeol Ryoo, Mo Youl Beck, In Soon Lee, Mi Jung Choi, Mi Woo Lee, Yoon-Koo Kang
Cancer Res Treat.2016;48(1):162-170. Published online 2015 September 1
DOI: http://dx.doi.org/10.4143/crt.2015.017
|
|
| 20 |
Efficacy of Imatinib in Patients with Platelet-Derived Growth Factor Receptor Alpha–Mutated Gastrointestinal Stromal Tumors
Changhoon Yoo, Min-Hee Ryu, Jungmin Jo, Inkeun Park, Baek-Yeol Ryoo, Yoon-Koo Kang
Cancer Res Treat.2016;48(2):546-552. Published online 2015 June 22
DOI: http://dx.doi.org/10.4143/crt.2015.015
|
|
